The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 113.00
Bid: 112.00
Ask: 113.50
Change: 0.75 (0.67%)
Spread: 1.50 (1.339%)
Open: 113.00
High: 113.00
Low: 111.50
Prev. Close: 112.00
LIT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Litigation Finance Agreement with Carillion

19 May 2021 07:18

RNS Number : 1187Z
Litigation Capital Management Ltd
19 May 2021
 

19 May 2021

 

Litigation Capital Management Limited

("LCM" or the "Company")

 

New Litigation Finance Agreement with Carillion for claim against former auditors

 

Litigation Capital Management Limited (AIM:LIT), an alternative asset manager specialising in dispute financing solutions internationally, announces that it has entered into a new litigation finance agreement with certain Carillion entities (in liquidation).

 

The agreement to provide a litigation finance facility is to fund a claim in the Commercial Court of the High Court of Justice of England & Wales against the Carillion group's former auditors, KPMG. The claim arises from KPMG's conduct of its audits of the Group's financial statements. The losses which form the subject matter of the claim are expected to exceed £250 million.

 

Carillion was the largest corporate collapse in the building and construction industry in UK history.

 

LCM continues to demonstrate its ability to access high quality investment opportunities, enabling long term value creation for shareholders and investors. The litigation finance facility with Carillion further strengthens the Company's existing, high quality, portfolio of investments.

 

Patrick Moloney, CEO of LCM, commented: "As a pioneer of the litigation finance industry, LCM has long and deep experience in funding insolvency related disputes. As such, LCM is extremely well placed to tailor a finance package to pursue these claims."

 

Nick Rowles-Davies, Executive Vice Chairman of LCM, commented: "This investment demonstrates LCM's prominence and pedigree in the disputes finance industry and in particular, LCM's position as funder of choice in the UK insolvency market and we are delighted to be supporting thousands of creditors who have suffered as a consequence of the biggest insolvency in recent UK history."

 

 

 

Enquiries

 

Litigation Capital Management

c/o Alma PR 

Patrick Moloney, Chief Executive Officer

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

Alma PR

Tel: 020 3405 0205

Justine James

LCM@almapr.co.uk

Susie Hudson

Kieran Breheny

Molly Gretton

 

NOTES TO EDITORS

 

Litigation Capital Management (LCM) is a leading international provider of litigation financing solutions. This includes single-case and portfolios across; class actions, commercial claims, claims arising out of insolvency and international arbitration. LCM has an unparalleled track record, driven by effective project selection, active project management and robust risk management.

 

Headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTSFWSMUEFSEFI
Date   Source Headline
15th Oct 20207:00 amRNSHolding(s) in Company
23rd Sep 20204:26 pmRNSHolding(s) in Company
22nd Sep 20207:00 amRNSFinal Results
10th Sep 20202:57 pmRNSHolding(s) in Company
8th Sep 20207:00 amRNSNotice of Results
24th Aug 20207:00 amRNSFunding of Corporate Portfolio Transaction
18th Aug 20207:00 amRNSAppointment of Non-Executive Director
13th Aug 20207:16 amRNSDisputes Finance Facility with Global Law Firm
10th Jul 20207:04 amRNSMarket Update
6th Jul 20204:40 pmRNSSecond Price Monitoring Extn
6th Jul 20204:35 pmRNSPrice Monitoring Extension
2nd Jul 202010:42 amRNSBoard Updates
26th May 20207:00 amRNSAustralian Regulation of Litigation Funders
22nd May 20204:41 pmRNSSecond Price Monitoring Extn
22nd May 20204:36 pmRNSPrice Monitoring Extension
20th Apr 20207:00 amRNSConclusion of Joint Venture Arrangement
3rd Apr 20207:08 amRNSManagement Update and Corporate Reorganisation
24th Mar 20207:00 amRNSFinal closure of US$150 million fund
23rd Mar 20207:41 amRNSDirector/PDMR Shareholding
17th Mar 20207:00 amRNSHalf-year Report
10th Mar 20207:00 amRNSFirst close of a new US$150 million fund
13th Feb 20207:00 amRNSNotice of Results
6th Feb 202012:07 pmRNSSecond Price Monitoring Extn
6th Feb 202012:02 pmRNSPrice Monitoring Extension
20th Dec 20198:04 amRNSCase Investment Settlement Update
16th Dec 20194:41 pmRNSSecond Price Monitoring Extn
16th Dec 20194:35 pmRNSPrice Monitoring Extension
11th Dec 201912:07 pmRNSSecond Price Monitoring Extn
11th Dec 201912:02 pmRNSPrice Monitoring Extension
10th Dec 20197:00 amRNSCapital Markets Event and Third-Party Fund Update
2nd Dec 20197:00 amRNSNotice of Dividend Currency Exchange Rate
21st Nov 20199:30 amRNSHolding(s) in Company
21st Nov 20198:25 amRNSResult of AGM
18th Nov 201912:23 pmRNS2019 Annual Report & Accounts
12th Nov 201912:07 pmRNSSecond Price Monitoring Extn
12th Nov 201912:02 pmRNSPrice Monitoring Extension
6th Nov 20197:00 amRNSAppointment of Joint Broker
1st Nov 201911:23 amRNSIncentive Awards
16th Oct 20198:00 amRNSNotice of Annual General Meeting
30th Sep 201912:00 pmRNSHolding(s) in Company
30th Sep 201912:00 pmRNSHolding(s) in Company
13th Sep 20193:01 pmRNSHolding(s) in Company
10th Sep 20197:00 amRNSFinal Results
2nd Sep 20197:30 amRNSNotice of Results
17th Jul 201910:42 amRNSHolding(s) in Company
28th Jun 201911:44 amRNSConditional Settlement of Litigation Project
13th Jun 20197:00 amRNSFunding of Corporate Portfolio Transaction
3rd Jun 20198:59 amRNSNotice of Dividend Currency Exchange Rate
28th May 20197:42 amRNSCourt Approval Settlement and Pipeline Update
8th Apr 201910:14 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.